Dark Forest Capital Management’s NovoCure NVCR Stock Holding History

Dark Forest Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.21M	Buy	79,908 +67,376	+538%	+$1.02M	0.08%	444
2026 Q1	$137K	Buy	+12,532	New	+$157K	0.01%	756
2025 Q4	–	Sell	-177,830	Closed	-$2.3M	–	1228
2025 Q3	$2.3M	Buy	+177,830	New	+$2.38M	0.09%	414
2025 Q2	–	Sell	-77,873	Closed	-$1.39M	–	1420
2025 Q1	$1.39M	Buy	+77,873	New	+$1.77M	0.06%	531
2022 Q3	–	Sell	-31	Closed	-$2K	–	1348
2022 Q2	$2K	Buy	+31	New	+$2.33K	﹤0.01%	735
2022 Q1	–	Sell	-170	Closed	-$13K	–	1610
2021 Q4	$13K	Buy	+170	New	+$17.1K	﹤0.01%	838

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Dark Forest Capital Management's NVCR Position: Q2 2026 in Review

Dark Forest Capital Management increased its NovoCure (NVCR) stake by 538% in Q2 2026, buying an estimated $1.02M and bringing the position to 79,908 shares worth $1.21M. The position accounts for 0.08% of the portfolio, ranked #444.

Dark Forest Capital Management first reported a position in NVCR in Q4 2021 and has held it in 6 quarters since. The position peaked at $2.3M in Q3 2025. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

Dark Forest Capital Management held 79,908 shares of NovoCure worth $1.21M as of Q2 2026.
Dark Forest Capital Management bought 67,376 NovoCure shares in Q2 2026, an estimated $1.02M.
NovoCure made up 0.08% of Dark Forest Capital Management's portfolio in Q2 2026, its #444 holding.
Dark Forest Capital Management first reported a position in NovoCure in Q4 2021 and has held it in 6 quarters since.
Dark Forest Capital Management's NovoCure position peaked at $2.3M in Q3 2025.
218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.